Skip to main navigation Skip to search Skip to main content

CTIP2 is a negative regulator of P-TEFb

  • Thomas Cherrier
  • , Valentin Le Douce
  • , Sebastian Eilebrecht
  • , Raphael Riclet
  • , Céline Marban
  • , Franck Dequiedt
  • , Yannick Goumon
  • , Jean Christophe Paillart
  • , Mathias Mericskay
  • , Ara Parlakian
  • , Pedro Bausero
  • , Wasim Abbas
  • , Georges Herbein
  • , Siavash K. Kurdistani
  • , Xavier Grana
  • , Benoit Van Driessche
  • , Christian Schwartz
  • , Ermanno Candolfi
  • , Arndt G. Benecke
  • , Carine Van Lint
  • Olivier Rohr
  • Université de Strasbourg
  • University of Liege
  • Unité 955
  • CNRS
  • University of California at Los Angeles
  • Sorbonne Université
  • Université de Franche-Comté
  • Temple University
  • Université libre de Bruxelles
  • Institut universitaire de France

Research output: Contribution to journalArticlepeer-review

81 Scopus citations

Abstract

The positive transcription elongation factor b (P-TEFb) is involved in physiological and pathological events including inflammation, cancer, AIDS, and cardiac hypertrophy. The balance between its active and inactive form is tightly controlled to ensure cellular integrity. We report that the transcriptional repressor CTIP2 is a major modulator of P-TEFb activity. CTIP2 copurifies and interacts with an inactive P-TEFb complex containing the 7SK snRNA and HEXIM1. CTIP2 associates directly with HEXIM1 and, via the loop 2 of the 7SK snRNA, with P-TEFb. In this nucleoprotein complex, CTIP2 significantly represses the Cdk9 kinase activity of P-TEFb. Accordingly, we show that CTIP2 inhibits large sets of P-TEFb- and 7SK snRNA-sensitive genes. In hearts of hypertrophic cardiomyopathic mice, CTIP2 controls P-TEFb-sensitive pathways involved in the establishment of this pathology. Overexpression of the β-myosin heavy chain protein contributes to the pathological cardiac wall thickening. The inactive P-TEFb complex associates with CTIP2 at the MYH7 gene promoter to repress its activity. Taken together, our results strongly suggest that CTIP2 controls P-TEFb function in physiological and pathological conditions.

Original languageEnglish
Pages (from-to)12655-12660
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume110
Issue number31
DOIs
StatePublished - Jul 30 2013

Keywords

  • Animals
  • Cardiac Myosins/genetics
  • Cardiomegaly/genetics
  • Cyclin-Dependent Kinase 9/genetics
  • HEK293 Cells
  • Humans
  • Mice
  • Myosin Heavy Chains/genetics
  • Positive Transcriptional Elongation Factor B/genetics
  • Promoter Regions, Genetic
  • Protein Structure, Secondary
  • RNA, Small Nuclear/genetics
  • RNA-Binding Proteins/genetics
  • Repressor Proteins/genetics
  • Transcription Factors/genetics
  • Tumor Suppressor Proteins/genetics

Fingerprint

Dive into the research topics of 'CTIP2 is a negative regulator of P-TEFb'. Together they form a unique fingerprint.

Cite this